Lung Cancer | Topics

Neoadjuvant Nivolumab Plus Chemo Improves Pathological Complete Response in Resectable NSCLC
April 10, 2021

The CheckMate-816 trial is the first positive phase 3 trial demonstrating a significant improvement in pathologic response with neoadjuvant immunotherapy plus chemotherapy in resectable non-small cell lung cancer.

Nikki Martin on LUNGevity’s “No One Missed Campaign” Focusing on Biomarker Testing Access
March 30, 2021

CancerNetwork® spoke with Nikki Martin of the LUNGevity Foundation regarding the “No One Missed” campaign working to provide education and awareness to patients with lung cancer.

Diagnostic AI Tool for Identifying Early-Stage Lung Cancer Earns FDA 150(k) Clearance
March 24, 2021

The Virtual Nodule Clinic artificial intelligence–powered clinical decision support tool was cleared by the FDA for detection of early-stage lung cancer in lung nodules detected by a CT scan.